HEADER VIRAL PROTEIN,HYDROLASE/INHIBITOR 17-AUG-23 8TV6 TITLE SARS-COV-2 MAC1 IN COMPLEX WITH MDOLL-0169 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAPAIN-LIKE PROTEASE NSP3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MACRODOMAIN 1; COMPND 5 SYNONYM: NON-STRUCTURAL PROTEIN 3,NSP3,PL2-PRO,PAPAIN-LIKE COMPND 6 PROTEINASE,PL-PRO; COMPND 7 EC: 3.4.19.12,3.4.22.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: SARS-COV-2, 2019-NCOV, COVID-19 VIRUS; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: REP, 1A-1B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE, MACRODOMAIN, INHIBITOR, COVID-19, VIRAL PROTEIN, KEYWDS 2 HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.WAZIR,M.MAKSIMAINEN,L.LEHTIO REVDAT 3 08-MAY-24 8TV6 1 JRNL REVDAT 2 01-MAY-24 8TV6 1 JRNL REVDAT 1 17-APR-24 8TV6 0 JRNL AUTH S.WAZIR,T.A.O.PARVIAINEN,J.J.PFANNENSTIEL,M.T.H.DUONG, JRNL AUTH 2 D.CLUFF,S.T.SOWA,A.GALERA-PRAT,D.FERRARIS,M.M.MAKSIMAINEN, JRNL AUTH 3 A.R.FEHR,J.P.HEISKANEN,L.LEHTIO JRNL TITL DISCOVERY OF 2-AMIDE-3-METHYLESTER THIOPHENES THAT TARGET JRNL TITL 2 SARS-COV-2 MAC1 AND REPRESS CORONAVIRUS REPLICATION, JRNL TITL 3 VALIDATING MAC1 AS AN ANTIVIRAL TARGET. JRNL REF J.MED.CHEM. V. 67 6519 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38592023 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02451 REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 27365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1331 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1499 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2518 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 217 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.25000 REMARK 3 B22 (A**2) : 0.86000 REMARK 3 B33 (A**2) : -0.60000 REMARK 3 B12 (A**2) : 0.21000 REMARK 3 B13 (A**2) : -0.27000 REMARK 3 B23 (A**2) : 0.47000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.138 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.133 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.090 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.811 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2667 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2612 ; 0.003 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3624 ; 1.446 ; 1.638 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6013 ; 1.406 ; 1.600 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 347 ; 6.987 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 119 ;40.616 ;24.622 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 448 ;13.765 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;17.817 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 341 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3052 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 575 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1346 ; 0.865 ; 1.410 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1345 ; 0.864 ; 1.410 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1683 ; 1.385 ; 2.110 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1684 ; 1.385 ; 2.110 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1321 ; 1.392 ; 1.659 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1322 ; 1.391 ; 1.660 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1934 ; 2.199 ; 2.399 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2989 ; 3.406 ;17.930 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2959 ; 3.307 ;17.762 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8TV6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000276494. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9655 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27365 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 37.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 1.050 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.74 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NEEDLE LIKE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CHES PH 9.5, 32% PEG (V/V) 3000, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 LEU A 169 REMARK 465 GLU A 170 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 GLU B 170 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 86 -126.88 55.99 REMARK 500 HIS B 86 -130.18 54.03 REMARK 500 REMARK 500 REMARK: NULL DBREF 8TV6 A 2 170 UNP P0DTD1 R1AB_SARS2 1024 1192 DBREF 8TV6 B 2 170 UNP P0DTD1 R1AB_SARS2 1024 1192 SEQADV 8TV6 SER A 0 UNP P0DTD1 EXPRESSION TAG SEQADV 8TV6 MET A 1 UNP P0DTD1 EXPRESSION TAG SEQADV 8TV6 SER B 0 UNP P0DTD1 EXPRESSION TAG SEQADV 8TV6 MET B 1 UNP P0DTD1 EXPRESSION TAG SEQRES 1 A 171 SER MET GLU VAL ASN SER PHE SER GLY TYR LEU LYS LEU SEQRES 2 A 171 THR ASP ASN VAL TYR ILE LYS ASN ALA ASP ILE VAL GLU SEQRES 3 A 171 GLU ALA LYS LYS VAL LYS PRO THR VAL VAL VAL ASN ALA SEQRES 4 A 171 ALA ASN VAL TYR LEU LYS HIS GLY GLY GLY VAL ALA GLY SEQRES 5 A 171 ALA LEU ASN LYS ALA THR ASN ASN ALA MET GLN VAL GLU SEQRES 6 A 171 SER ASP ASP TYR ILE ALA THR ASN GLY PRO LEU LYS VAL SEQRES 7 A 171 GLY GLY SER CYS VAL LEU SER GLY HIS ASN LEU ALA LYS SEQRES 8 A 171 HIS CYS LEU HIS VAL VAL GLY PRO ASN VAL ASN LYS GLY SEQRES 9 A 171 GLU ASP ILE GLN LEU LEU LYS SER ALA TYR GLU ASN PHE SEQRES 10 A 171 ASN GLN HIS GLU VAL LEU LEU ALA PRO LEU LEU SER ALA SEQRES 11 A 171 GLY ILE PHE GLY ALA ASP PRO ILE HIS SER LEU ARG VAL SEQRES 12 A 171 CYS VAL ASP THR VAL ARG THR ASN VAL TYR LEU ALA VAL SEQRES 13 A 171 PHE ASP LYS ASN LEU TYR ASP LYS LEU VAL SER SER PHE SEQRES 14 A 171 LEU GLU SEQRES 1 B 171 SER MET GLU VAL ASN SER PHE SER GLY TYR LEU LYS LEU SEQRES 2 B 171 THR ASP ASN VAL TYR ILE LYS ASN ALA ASP ILE VAL GLU SEQRES 3 B 171 GLU ALA LYS LYS VAL LYS PRO THR VAL VAL VAL ASN ALA SEQRES 4 B 171 ALA ASN VAL TYR LEU LYS HIS GLY GLY GLY VAL ALA GLY SEQRES 5 B 171 ALA LEU ASN LYS ALA THR ASN ASN ALA MET GLN VAL GLU SEQRES 6 B 171 SER ASP ASP TYR ILE ALA THR ASN GLY PRO LEU LYS VAL SEQRES 7 B 171 GLY GLY SER CYS VAL LEU SER GLY HIS ASN LEU ALA LYS SEQRES 8 B 171 HIS CYS LEU HIS VAL VAL GLY PRO ASN VAL ASN LYS GLY SEQRES 9 B 171 GLU ASP ILE GLN LEU LEU LYS SER ALA TYR GLU ASN PHE SEQRES 10 B 171 ASN GLN HIS GLU VAL LEU LEU ALA PRO LEU LEU SER ALA SEQRES 11 B 171 GLY ILE PHE GLY ALA ASP PRO ILE HIS SER LEU ARG VAL SEQRES 12 B 171 CYS VAL ASP THR VAL ARG THR ASN VAL TYR LEU ALA VAL SEQRES 13 B 171 PHE ASP LYS ASN LEU TYR ASP LYS LEU VAL SER SER PHE SEQRES 14 B 171 LEU GLU HET PEG A 201 7 HET V83 B 201 26 HET GOL B 202 6 HET PEG B 203 7 HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM V83 (1R,6R)-6-{[3-(METHOXYCARBONYL)-5,6,7,8-TETRAHYDRO-4H- HETNAM 2 V83 CYCLOHEPTA[B]THIOPHEN-2-YL]CARBAMOYL}CYCLOHEX-3-ENE-1- HETNAM 3 V83 CARBOXYLIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 PEG 2(C4 H10 O3) FORMUL 4 V83 C19 H23 N O5 S FORMUL 5 GOL C3 H8 O3 FORMUL 7 HOH *217(H2 O) HELIX 1 AA1 ASP A 22 LYS A 31 1 10 HELIX 2 AA2 GLY A 47 THR A 57 1 11 HELIX 3 AA3 ASN A 59 GLY A 73 1 15 HELIX 4 AA4 ASN A 99 GLY A 103 5 5 HELIX 5 AA5 GLN A 107 ASN A 115 1 9 HELIX 6 AA6 PHE A 116 HIS A 119 5 4 HELIX 7 AA7 ALA A 129 GLY A 133 5 5 HELIX 8 AA8 ASP A 135 VAL A 147 1 13 HELIX 9 AA9 ASP A 157 SER A 166 1 10 HELIX 10 AB1 ASP B 22 LYS B 31 1 10 HELIX 11 AB2 GLY B 47 THR B 57 1 11 HELIX 12 AB3 ASN B 59 GLY B 73 1 15 HELIX 13 AB4 ASN B 99 GLY B 103 5 5 HELIX 14 AB5 GLN B 107 ASN B 115 1 9 HELIX 15 AB6 PHE B 116 HIS B 119 5 4 HELIX 16 AB7 ALA B 129 GLY B 133 5 5 HELIX 17 AB8 ASP B 135 VAL B 147 1 13 HELIX 18 AB9 ASP B 157 LEU B 169 1 13 SHEET 1 AA1 4 LEU A 10 LYS A 11 0 SHEET 2 AA1 4 VAL A 16 ASN A 20 -1 O ILE A 18 N LEU A 10 SHEET 3 AA1 4 ASN A 150 VAL A 155 1 O LEU A 153 N TYR A 17 SHEET 4 AA1 4 VAL A 121 ALA A 124 1 N LEU A 122 O TYR A 152 SHEET 1 AA2 3 VAL A 34 ALA A 38 0 SHEET 2 AA2 3 HIS A 91 VAL A 95 1 O VAL A 95 N ASN A 37 SHEET 3 AA2 3 SER A 80 SER A 84 -1 N LEU A 83 O CYS A 92 SHEET 1 AA3 4 LEU B 10 LYS B 11 0 SHEET 2 AA3 4 VAL B 16 ASN B 20 -1 O ILE B 18 N LEU B 10 SHEET 3 AA3 4 ASN B 150 VAL B 155 1 O LEU B 153 N TYR B 17 SHEET 4 AA3 4 VAL B 121 ALA B 124 1 N LEU B 122 O TYR B 152 SHEET 1 AA4 3 VAL B 34 ALA B 38 0 SHEET 2 AA4 3 HIS B 91 VAL B 95 1 O VAL B 95 N ASN B 37 SHEET 3 AA4 3 SER B 80 SER B 84 -1 N LEU B 83 O CYS B 92 CRYST1 30.216 37.765 64.085 95.59 98.13 90.44 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033095 0.000255 0.004774 0.00000 SCALE2 0.000000 0.026480 0.002647 0.00000 SCALE3 0.000000 0.000000 0.015841 0.00000